WitrynaStock analysis for Immune Therapeutics Inc (IMUN:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile. WitrynaImmune Therapeutics Appoints H. Louis Salomonksy to its Board of Directors. ORLANDO, FL, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTC PINK:IMUN) ("Immune" or "IMUN"), a specialty pharmaceutical company involved in the acquisition, development, and commercialization of pharmaceutical and …
Immune Therapeutics Inc (IMUN) Debt Coverage starting from the …
Witryna24 mar 2024 · Der aktuelle Immune Therapeutics Realtimekurs ( 24.03.23) liegt bei 0,650 $. Damit ist die Immune Therapeutics Aktie (A3CMTA) in 24 Stunden um +8,33 % gestiegen. Auf 7 Tage gesehen hat sich der ... Witryna5 kwi 2024 · As of the end of day on the 2024-04-05, the price of an Immune Therapeutics Inc (IMUN) share was $0.600. What is the 52-week high and low for Immune Therapeutics Inc Stock? The 52-week high for Immune Therapeutics Inc Stock is $2.85 and the 52-week low is $0.370. can i get another sba loan
Immune Therapeutics, Inc. (IMUN) 股價、新聞、報價和過往記錄
Witryna0001559356 false FY ... WitrynaImmune Therapeutics, Inc. Announces the Resignation of Michael Sander as a Director Jan 28 In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. Witryna14 kwi 2024 · PALO ALTO, Calif., April 14, 2024 -- ( BUSINESS WIRE )--Immune-Onc Therapeutics, Inc. ("Immune-Onc"), a private, clinical-stage cancer immunotherapy company developing novel biotherapeutics ... fitting into race boots motorcycle